Patent Assignment
Reel/Frame 044891/0376
Assignment of Assignor's Interest
Recorded: 2017-12-13
Pages: 14
Assignor
MALLINCKRODT LLC
Executed: 2017-12-13
Assignee
SPECGX LLC
385 MARSHALL AVENUE, WEBSTER GROVES, MISSOURI, 63119
Covered Properties
(127)
Bulk Packaging System and Method for Retarding Caking of Organic and Inorganic Chemical Compounds
Patent:
6,102,198 →
Application:
08/862,010 →
Process for Preparing a Morphinan Derivative
Patent:
5,912,347 →
Application:
08/939,245 →
Bulk Packaging System & Method for Retarding Caking of Organic and Inorganic Chemical Compounds
Patent:
6,308,826 →
Application:
09/296,164 →
Bulk packaging system and method for retarding caking of organic and inorganic chemical compounds
Patent:
6,343,458 →
Application:
09/560,043 →
Preparation of Codeine from Morphine
Patent:
6,579,985 →
Application:
10/274,702 →
Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
Methylphenidate Solution and Associated Methods of Administration and Produciton
Stearate Composition and Method of Production Thereof
Stearate Composition and Method
Opiate Intermediates and Methods of Synthesis
Opiate Intermediates and Methods of Synthesis
Opiate Intermediates and Methods of Synthesis
Matrix-Based Pulse Release Pharmaceutical Formulation
Process for Preparing Morphinan-6-One Products with Low Levels of Alpha, Beta-Unsaturated Ketone Compounds
Synthetic Route to 14-Hydroxyl Opiates Through 1-Halo-Thebaine or Analogs
Dye Compounds as Photoactive Agents
Use of Oripavine as a Starting Material For Buprenorphine
Solid Support for Fmoc-Solid Phase Synthesis of Peptides
Composition and Method for the Release of Protected Peptides from a Resin
Zero-Order Modified Release Solid Dosage Forms
Application:
12/299,944 →
Publication:
US 2009/0110728
N-Demethylation of N-Methyl Morphinans
Sinomenine derivatives and processes for their synthesis
Process for the Preparation of Buprenorphine and Derivatives for Buprenorphine
Process and Compounds for the Production of (+)Opiates
Processes for the Preparation of Normorphinan Salts
Processes for the Production of (+)- "Nal" Morphinan Compounds
Process for the Preparation of 3-Hydroxymorphinan Derivatives
Preparation of Substituted Morphinan-6-Ones and Salts and Intermediates Thereof
Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates
Processes and Compounds for the Preparation of Normorphinans
Preparation of Amides from an Acid and Amine for Intermediates in the Synthesis of Morphinans
Preparation of 3,4-Dihydroisoquinolines in the Synthesis of Morphinans
Process for the Preparation of Hexahydroisoquinolines from 1,2,3,4-Tetrahydroisoquinolines
Process for the Preparation of 6-Beta Hydroxy Morphinan Compounds
Preparation of Tetrahydroisoquinolines from Dihydroisoquinolines
Preparation of 3,4-Dihydroisoquinolines from an Acid and an Amine
Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
Preparation of Oxymorphone from Oripavine
Substituted Berbines and Processes for their Synthesis
Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
Processes for the Synthesis of Five and Six Membered Heterocyclic Rings
Berberine Compounds and Processes for the Preparation of Berberine Compounds
Processes for the Synthesis of Opiates Alkaloids with Reduced Impurity Formation
Processes for Increasing the Yield of Opiate Alkaloid Derivatives
Processes for the Synthesis of Tertiary Amines
Processes for the Selective Amination of Ketomorphinans
Method of Purifying Crude Noscapine
Processes for the Alkylation of Norbuprenorphine with Reduced Impurity Formation
Processes for the Production of Buprenorphine with Reduced Impurity Formation
Recycling Process for Increasing the Yield of Opiate Alkaloid Derivatives
Processes for Synthesis of Opiate Alkaloid Derivatives
Novel Opiate Reduction Utilizing Catalytic Hydrogen Transfer Reaction
Crystalline and Amorphous Forms of Naltrexone Hydrochloride
Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates
Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates
Synthesis of Methylphenidate and Analogs Thereof
Crystalline Forms of Naltrexone Methobromide
Preparation of N-Alkylated Opiates by Reductive Amination
Process for the Reductive Alkylation of Normorphinans
(+)-Morphinanium Quaternary Salts and Processes for their Production
(+)-Morphinanium N-Oxides and Processes for their Production
(+)-6-Hydroxy-Morphinan or (+)-6-Amino-Morphinan Derivatives
Preparation of Saturated Ketone Morphinan Compounds by Catalytic Isomerization
Preparation of Saturated Ketone Morphinan Compounds
Solid Support for Fmoc-Solid Phase Synthesis of Peptide Acids
Reductive Amination of 6-Keto Normorphinans by Catalytic Hydrogen Transfer
Preparation of 6-Alpha-Amino N-Substituted Morphinans by Catalytic Hydrogen Transfer
Method for the Enrichment of Buprenorphine Using Chromatographic Techniques
3-Oxy-Hydromorphone Derivatives
Preparation of 10-Keto Morphinans by Benzylic Oxidation
Methods for Producing Hydrocodone, Hydromorphone or a Derivative Thereof
Heterogeneous Ruthenium Metal Catalyst for the Production of Hydrocodone, Hydromorphone or a Derivative Thereof
One-Pot Preparation of Hexahydroisoquinolines from Amides
One-Pot Preparation of Hexahydroisoquinolines from Dihydroisoquinolines
Disposable Transdermal Patch Packaging
Apparatuses and Methods for Storing Pharmaceutical Product
Systems and Methods for Timing Dosage Periods
Systems and Methods for Manging Use of a Medicament
Container and Method for Facilitating Disposal of Unused Pharmaceutical Product
Preparation of Saturated Ketone Morphinan Compounds Having Low Metal Content
Pen-Type Pharmaceutical Product Dispenser
Sealable Secondary Packaging for Pharmaceutical Product Blister Pack
Tandem Process for Preparing N-Alkyl Morphinans
N-Demethylation of 6-Keto Morphinans
Pharmacutical Product Blister Pack Lockable Within Secondary Packaging
Process for the Preparation of Sufentanil Base and Related Compounds
Processes for Preparing Morphinan-6-One Products with Low Levels of Alpha Beta-Unsaturated Compounds
Compounds Containing Acyclic N-N Bonds for Phototherapy
Sinomenine Derivatives and Processes for their Synthesis
Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers
Reductive Amination of 6-Keto Morphinans by Catalytic Hydrogen Transfer
Production of Alkaloids without the Isolation of Intermediates
Sealable Secondary Packaging for Pharmaceutical Product Blister Pack
One-Pot Preparation of Hexahydroisoquinolines from Amides
One Pot Process for Producing 6-Hydroxyl Nal-Opiate
Immediate Release Pharmaceutical Compositions with Abuse Deterrent Properties
Application:
13/865,244 →
Publication:
US 2013/0280176
Immediate Release, Abuse Deterrent Pharmaceutical Compositions
Sample Digester with Independently Controllable Sample Temperature and Ultraviolet Irradiation
Patent:
9,086,349 →
Application:
13/904,571 →
Container and Method for Facilitating Disposal of Unused Pharmaceutical Product
Extended Release, Abuse Deterrent Pharmaceutical Compositions
(+)-6-Hydroxy-Morphinan or (+)-6-Amino-Morphinan Derivatives
Sealable Secondary Packaging for Pharmaceutical Product Blister Pack
Suspicious Order Monitoring System and Method
Patent:
10,089,678 →
Application:
14/192,971 →
Abuse Deterrent Solid Dosage Form for Immediate Release with Functional Score
Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers
Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers
Method and Apparatus for Disposal of a Pharmaceutical Product Blister Card
Application:
14/336,357 →
Publication:
US 2014/0331610
Pharmaceutical Product Container with Permanent Locking Mechanism
PROCESS FOR THE PREPARATION OF RADIOIODINATED 3-FLUOROPROPYL-NOR-Beta-CIT
Substituted Berbines and Their Synthesis
Convenient Preparation of N-Substituted Morphinan-6-Ols from Morphinan-6-Ones
Production of 6-Hydroxy Morphinans Without the Isolation of Intermediates
Preparation of Normorphinans
Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
Sealable Secondary Packaging for Pharmaceutical Product Blister Pack
Spray Dried Compositions Having Different Dissolution Profiles and Processes for Their Preparation
Oxidative Dearomatization of Berbines
Abuse Deterrent Immediate Release Formulations Comprising Non-Cellulose Polysaccharides
Process for Preparing Substituted Phenylalkanes
Preparation of Sufentanil Citrate and Sufentanil Base
Two-Step Process for Preparing 3-Substituted Phenylalkylamines
Substituted Berbines and Processes for Their Synthesis
Glucomannan Containing Pharmaceutical Compositions with Extended Release and Abuse Deterrent Properties
Extended Release, Abuse Deterrent Pharmaceutical Compositions
Extended Release, Abuse Deterrent Dosage Forms
Systems and Methods for High Humidity Curing Within Tablet Coating System
Immediate Release, Abuse Deterrent Pharmaceutical Compositions
Application:
15/714,137 →
Publication:
US 2018/0008532
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Feb 9, 2017
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 041669/0792 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 032480, Frame 0001
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH
Reel/Frame 065609/0322 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Intellectual Property Security Agreement
Jul 31, 2025
From: SPECGX LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 072313/0063 →
Release of Security Interest
Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →